TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19502859

Group type: EXPERIMENTAL
Intervention: Methylene blue staining
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard nodal harvest (unstained)
Number of subjects: 50
Study: 18000144

Group type: EXPERIMENTAL
Intervention: Rapid-paced walking
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Usual-paced walking
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Self-reported measures of physical function (including ADLs)
Number of subjects: 3035
Study: 15482051

Group type: EXPERIMENTAL
Intervention: Synchronous Internet‐delivered intervention (chat room) for improving eating habits and body image
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 60
Study: 11853301

Group type: EXPERIMENTAL
Intervention: Lower uterine segment sweeping
Number of subjects: 400

Group type: COMPARATOR
Intervention: Routine vaginal examination (Control)
Number of subjects: 400
Study: 9209168

Group type: COMPARATOR
Intervention: 0 g soy protein
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 5 g soy protein
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10 g soy protein
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 g soy protein
Number of subjects: 14
Study: 16353603

Group type: EXPERIMENTAL
Intervention: Etiocholanedione (ED), 4 gm daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2454359

Group type: EXPERIMENTAL
Intervention: Acute administration of carvedilol (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic administration of carvedilol
Number of subjects: 0
Study: 29414482

Group type: EXPERIMENTAL
Intervention: 5-session couple-based HIV/HCV and overdose prevention intervention
Number of subjects: 479

Group type: COMPARATOR
Intervention: 5-session Wellness Promotion and overdose prevention comparison condition
Number of subjects: 479
Study: 26796609

Group type: EXPERIMENTAL
Intervention: 1.0 minimum alveolar concentration of desflurane and 1.0 ng/mL effect‐site concentration of remifentanil (group DR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 1.5 minimum alveolar concentration desflurane (group D)
Number of subjects: 62
Study: 24942380

Group type: EXPERIMENTAL
Intervention: Phototherapy with 10 J dose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phototherapy with 30 J dose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phototherapy with 50 J dose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phototherapy with all doses (10 J, 30 J, 50 J)
Number of subjects: 40
Study: 22228000

Group type: EXPERIMENTAL
Intervention: Early and high intravenous (IV) amino acid (AA) supplementation starting at 0.5 g.kg(-1).day(-1) and increased to 3 g.kg(-1).day(-1)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard intravenous (IV) amino acid (AA) supplementation starting at 2 g.kg(-1).day(-1) and increased to 4 g.kg(-1).day(-1)
Number of subjects: 51
Study: 20051728

Group type: EXPERIMENTAL
Intervention: Active stretching (group 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Passive stretching (group 2)
Number of subjects: 65
Study: 18552370

Group type: EXPERIMENTAL
Intervention: Supervised training programme (very light resistance and toning exercises, 80 sessions, 3 times/week, 35 min/session from weeks 12-13 to weeks 38-39)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 142
Study: 16396746

Group type: EXPERIMENTAL
Intervention: Experimental protocols in randomized controlled trials (RCT) for pediatric cancers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference treatment modalities
Number of subjects: 0
Study: 15354622

Group type: EXPERIMENTAL
Intervention: Home-based depressive symptom intervention with master's-prepared psychiatric mental health nurses
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual care/waiting list
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Home-based depressive symptom intervention
Number of subjects: 16
Study: 10953194

Group type: EXPERIMENTAL
Intervention: Transplantation of cultured human neuronal cells
Number of subjects: 12
Study: 8666628

Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement
Number of subjects: 76

Group type: COMPARATOR
Intervention: Washout
Number of subjects: 76
Study: 1486224

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (MCF: mitoxantrone, cyclophosphamide, 5‐fluorouracil)
Number of subjects: 40
Study: 6428372

Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose, 2.95 mg/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (mean dose, 1,166 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 3549803

Group type: EXPERIMENTAL
Intervention: Twice-daily 2% topical minoxidil for 12 months
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 3% topical minoxidil for 8 to 12 months followed by twice-daily application for 1 more year
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Once-daily topical minoxidil after 2 years
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Twice-daily topical minoxidil throughout the study
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo for the first 4 months
Number of subjects: 41
Study: 30520168

Group type: EXPERIMENTAL
Intervention: Calcipotriol 50 μg/g plus betamethasone dipropionate 0.5 mg/g cutaneous foam (Cal/BD foam)
Number of subjects: 837
Study: 28899341

Group type: EXPERIMENTAL
Intervention: Home-based training program (12 weeks) including exercises to improve strength/power, postural control, individual walking trails, and patient-specific motivational strategies
Number of subjects: 101

Group type: COMPARATOR
Intervention: Unspecific flexibility exercise (12 weeks)
Number of subjects: 101
Study: 26525030

Group type: EXPERIMENTAL
Intervention: Fu Chan Xue Jing
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (basic medical abortion)
Number of subjects: 86
Study: 24490242

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 1988

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1988
Study: 21543987

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 18471324

Group type: EXPERIMENTAL
Intervention: Online formative assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supplementary learning material (not specified if online or other forms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual clinical material
Number of subjects: 0
Study: 17101625

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation and nutritional counseling
Number of subjects: 25
Study: 11889149

Group type: EXPERIMENTAL
Intervention: Raloxifene (RLX) 60 mg/d
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 10 mg/d
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Raloxifene (RLX) 60 mg/d and Alendronate (ALN) 10 mg/d combined
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study: 9462526

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) at therapeutic concentrations
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.25 U/mL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Argatroban (1 ng/mL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 50
Study: 7622771

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg b.i.d.) + Coamoxiclav (1 g b.i.d.) for 3 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Doxycycline (100 mg b.i.d.) + Coamoxiclav (1 g b.i.d.) for 6 weeks
Number of subjects: 118
Study: 2239134

Group type: EXPERIMENTAL
Intervention: Chlorimipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 379929

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy and hormonal therapy (alternating chemotherapy and tamoxifen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients radiated in the same period who failed to meet entry criteria)
Number of subjects: 0
Study: 30411128

Group type: EXPERIMENTAL
Intervention: Pit and fissure sealing (Group A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preventive resin filling (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.5% fluoride coating combined with pit and fissure sealing (Group C)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.5% fluoride combined with preventive resin filling (Group D)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group with daily nursing brushing (Group E)
Number of subjects: 90
Study: 26361879

Group type: EXPERIMENTAL
Intervention: Etanercept plus MTX
Number of subjects: 205

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 205
Study: 24761456

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Summary control
Number of subjects: 95
Study: 22374183

Group type: COMPARATOR
Intervention: Troponin I <0.010 μg/L (n=2663)
Number of subjects: 6189

Group type: EXPERIMENTAL
Intervention: Troponin I ≥0.040 μg/L (n=497)
Number of subjects: 6189

Group type: COMPARATOR
Intervention: NT‐proBNP <387 ng/L
Number of subjects: 6189

Group type: EXPERIMENTAL
Intervention: NT‐proBNP >1402 ng/L
Number of subjects: 6189
Study: 20812540

Group type: COMPARATOR
Intervention: Intrarectal instillation of a lidocaine/prilocaine cream (EMLA R)
Number of subjects: 372

Group type: COMPARATOR
Intervention: 2.5% lidocaine gel
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Lidocaine spray (10 gr/100 ml)
Number of subjects: 372
Study: 19127003

Group type: EXPERIMENTAL
Intervention: Intervention not specified
Number of subjects: 0
Study: 17148517

Group type: EXPERIMENTAL
Intervention: Herbal magnetic corsets
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment (lumbar traction, medium frequency electrotherapy, and massage)
Number of subjects: 60
Study: 12670837

Group type: EXPERIMENTAL
Intervention: 300 mg testosterone enanthate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600 mg testosterone enanthate
Number of subjects: 0
Study: 10485531

Group type: EXPERIMENTAL
Intervention: Irrigating balanced salt solution supplemented with vancomycin (10 microg/ml)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group received salt solution only
Number of subjects: 118
Study: 9139272

Group type: EXPERIMENTAL
Intervention: Heart infarction with Q wave
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Heart infarction without Q wave
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 50
Study: 1657505

Group type: EXPERIMENTAL
Intervention: L‐[1‐13C]leucine continuous infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flooding amount of L‐[1‐13C]leucine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flooding amount of L‐[1‐13C]phenylalanine (0.05 g/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous injection of leucine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous injection of valine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injection of 0.05 g of L‐leucine/kg
Number of subjects: 0
Study: 7231912

Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Oral acetazolamide
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68
Study: 12519036

Group type: EXPERIMENTAL
Intervention: Ibuprofen isobutanolammonium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Benzydamine hydrochloride
Number of subjects: 30
Study: 29907211

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study: 26917157

Group type: EXPERIMENTAL
Intervention: Mate tea (MT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 12
Study: 24903461

Group type: EXPERIMENTAL
Intervention: Football training group (FG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 21949192

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BMI), n = 391
Number of subjects: 772

Group type: COMPARATOR
Intervention: Control group receiving two leaflets about alcohol, n = 381
Number of subjects: 772
Study: 20384428

Group type: EXPERIMENTAL
Intervention: 7 mg transdermal nicotine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 18418433

Group type: EXPERIMENTAL
Intervention: Standardized oral glucose load (75 g)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isovolumetric sham drink
Number of subjects: 19
Study: 15825072

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice per day
Number of subjects: 549

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 549
Study: 12152802

Group type: EXPERIMENTAL
Intervention: Indocyanine green angiography (ICGA) with infrared fundus camera
Number of subjects: 38
Study: 10782623

Group type: EXPERIMENTAL
Intervention: Primary open-angle glaucoma (POAG) diagnosis
Number of subjects: 1993

Group type: EXPERIMENTAL
Intervention: Pseudoexfoliation syndrome (PEX)
Number of subjects: 1993

Group type: EXPERIMENTAL
Intervention: Simple ocular hypertension
Number of subjects: 1993
Study: 8877661

Group type: EXPERIMENTAL
Intervention: Experimental group 1 (E-1; n = 80) received a new toothbrush, toothpaste, and instruction
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Experimental group 2 (E-2; n = 80) received toothbrush, toothpaste, dental floss, and instruction
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (C; n = 80) received only dental examinations
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Experimental groups (E-1 and E-2) during the preventive program
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: After the instructional program (6 months later)
Number of subjects: 240
Study: 1819034

Group type: EXPERIMENTAL
Intervention: EAA in a routine dose
Number of subjects: 110

Group type: COMPARATOR
Intervention: EAA in a much smaller dosage
Number of subjects: 110
Study: 6352887

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 99

Group type: COMPARATOR
Intervention: Chlorothiazide
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: High birth weight
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Low initial mean airway pressure
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Absence of intraventricular hemorrhage
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Diuresis
Number of subjects: 99
Study: 31078650

Group type: EXPERIMENTAL
Intervention: Smartwatch with real-time feedback
Number of subjects: 80
Study: 27340939

Group type: EXPERIMENTAL
Intervention: Balance Vestibular Rehabilitation Therapy (VRT) + Canalith Repositioning Maneuver (CRM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Canalith Repositioning Maneuver (CRM) only
Number of subjects: 14
Study: 27252251

Group type: EXPERIMENTAL
Intervention: n-3 PUFA therapy
Number of subjects: 0
Study: 23223966

Group type: EXPERIMENTAL
Intervention: Double-high insert (DH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medial-pivot insert (MP)
Number of subjects: 40
Study: 22574593

Group type: EXPERIMENTAL
Intervention: Modified Sijunzi Decoction (MSD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (cleaning enema)
Number of subjects: 32
Study: 20145567

Group type: EXPERIMENTAL
Intervention: Static stretching of quadriceps and triceps surae muscles for 10 minutes
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control condition (no stretching)
Number of subjects: 17
Study: 18042313

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 14

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 14
Study: 15808754

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (defined as glucose > or =7.8 mmol/l or 140 mg/dl)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Non-hyperglycemic patients (glucose < 7.8 mmol/l)
Number of subjects: 460
Study: 12154206

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sulphasalazine (SSZ)
Number of subjects: 126
Study: 9925069

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (3 mEq/kg NaHCO3)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sodium chloride (1 mEq/kg NaCl)
Number of subjects: 6
Study: 8431099

Group type: EXPERIMENTAL
Intervention: 30 mg of methylphenidate per day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 3309002

Group type: EXPERIMENTAL
Intervention: Bioprosthesis (Hancock porcine heterograft)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Mechanical prosthesis (Björk-Shiley spherical disc valve)
Number of subjects: 575
Study: 31325499

Group type: EXPERIMENTAL
Intervention: Locally produced food without additives (group 1)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Supermarket food (group 2)
Number of subjects: 159
Study: 29332101

Group type: EXPERIMENTAL
Intervention: Convolution Taping Method (CTM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-Convolution Taping Method (NCTM)
Number of subjects: 28
Study: 27552723

Group type: EXPERIMENTAL
Intervention: Trust and social engagement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy mistrust
Number of subjects: 0
Study: 25631734

Group type: EXPERIMENTAL
Intervention: BIS-monitored group (n=17)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-BIS-monitored group (n=17)
Number of subjects: 34
Study: 22615323

Group type: EXPERIMENTAL
Intervention: Experimental challenge with approximately 1800 Plasmodium falciparum-parasitized red blood cells (pRBCs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group inoculated with <180 pRBCs
Number of subjects: 10
Study: 20125070

Group type: EXPERIMENTAL
Intervention: Hyperbaric levobupivacaine (13.5 mg, intrathecally in 3 mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isobaric levobupivacaine (13.5 mg, intrathecally in 3 mL)
Number of subjects: 0
Study: 18429659

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon-α plus low-dose cytarabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness ratios
Number of subjects: 0
Study: 15953951

Group type: EXPERIMENTAL
Intervention: Randomization method specified
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Allocation concealment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Double blinding
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Reporting of withdrawals and dropouts
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intention to treat analysis
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Jadad score
Number of subjects: 28
Study: 11850261

Group type: EXPERIMENTAL
Intervention: Single oral dose of artesunate (0 to 250 mg) with a curative dose of oral mefloquine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Single doses of artesunate higher than 2 mg/kg
Number of subjects: 47
Study: 10069672

Group type: EXPERIMENTAL
Intervention: Verapamil (360 mg/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 8673823

Group type: EXPERIMENTAL
Intervention: Ivermectin treatment (6-monthly regime)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Ivermectin treatment (multiple doses)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Ivermectin treatment (at least three doses)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Ivermectin treatment (annual treatment interval)
Number of subjects: 335
Study: 1885274

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diatrizoate-meglumine
Number of subjects: 44
Study: 6416853

Group type: EXPERIMENTAL
Intervention: Oral 25-hydroxyvitamin D3 treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Before treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Change in absorption on treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 51Cr EDTA clearance measurement
Number of subjects: 48
Study: 30794762

Group type: EXPERIMENTAL
Intervention: Wii training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Task-specific training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 30808623

Group type: EXPERIMENTAL
Intervention: COBRA (combination of sulfasalazine, low-dose methotrexate, and initially high, step-down prednisolone)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Sulfasalazine monotherapy (SSZ)
Number of subjects: 155

Group type: COMPARATOR
Intervention: General population reference sample
Number of subjects: 155
Study: 27731538

Group type: EXPERIMENTAL
Intervention: Methotrexate (50 mg/m2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 80
Study: 25564804

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) 5 mg/kg body weight + immunomodulatory agent (azathioprine 1.5-3 mg/kg body weight per day or methotrexate 10-25 mg/week) continued up to week 54
Number of subjects: 99

Group type: COMPARATOR
Intervention: Infliximab (IFX) 5 mg/kg body weight + immunomodulatory agent discontinued after 26 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups (I and II)
Number of subjects: 99
Study: 24413701

Group type: EXPERIMENTAL
Intervention: Bayesian spatial random-effects modeling approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian spatial modeling
Number of subjects: 0
Study: 22984910

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) plus self-lymphatic drainage (SLD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD) with compression bandage (complex decongestive therapy)
Number of subjects: 30
Study: 19145115

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 218

Group type: COMPARATOR
Intervention: Balloon Angioplasty
Number of subjects: 218
Study: 17320553

Group type: EXPERIMENTAL
Intervention: CarboMedics
Number of subjects: 485

Group type: COMPARATOR
Intervention: St. Jude Medical
Number of subjects: 485
Study: 15346750

Group type: EXPERIMENTAL
Intervention: Immediate provisional restoration of Osseotite implants
Number of subjects: 38